Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bioactive Lipids as Chronic Myeloid Leukemia's Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors.
Front Immunol. 2022 Apr 13;13:840173. doi: 10.3389/fimmu.2022.840173. eCollection 2022.
Front Immunol. 2022.
PMID: 35493444
Free PMC article.
Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype.
Bassan VL, Barretto GD, de Almeida FC, Palma PVB, Binelli LS, da Silva JPL, Fontanari C, Castro RC, de Figueiredo Pontes LL, Frantz FG, de Castro FA.
Bassan VL, et al.
Med Oncol. 2022 Sep 29;39(12):223. doi: 10.1007/s12032-022-01825-6.
Med Oncol. 2022.
PMID: 36175590
Free PMC article.
Item in Clipboard
Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study.
Murbach B, Duarte G, Palma LC, Miranda E, Duffles G, Furlin GP, Toni I, De Souza C, Binelli L, Bassan VL, de Castro FA, de Figueiredo-Pontes LL, Pagnano KBB.
Murbach B, et al. Among authors: bassan vl.
Front Oncol. 2024 May 8;14:1393191. doi: 10.3389/fonc.2024.1393191. eCollection 2024.
Front Oncol. 2024.
PMID: 38779092
Free PMC article.
Item in Clipboard
Cite
Cite